- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Usta Atmaca H, Akbas F
The Effect of Short Term Alpha Lipoic Acid Administration on Adiponectin and Body Weight in Type 2 Diabetes Mellitus Patient
Acta Endo (Buc) 2017, 13 (4): 461-466doi: 10.4183/aeb.2017.461
Background. Alpha lipoic acid (ALA) acts as
essential co-factor for mitochondrion respiratory enzymes.
It has an increasing importance in diabetic neuropathy
treatment. Its positive effects on weight gain and metabolic
parameters have also been discussed. In this study, we
aimed to search for the effect of ALA on weight, appetite,
adiponectin and metabolic parameters in type 2 diabetes
mellitus patients.
Methods. This study is designed as a randomised,
double-blind, placebo controlled, prospective study. 23 type
2 diabetes mellitus patients with peripheral neuropathy (6
normal weight, 17 obese) and 21 normal weight control group
were included in the study. Patients were given 600mg/day
oral ALA for 6 weeks, added to their routine therapy. Body
mass index (BMI), adiponectin, fasting plasma glucose,
HbA1C, lipid parameters and CRP levels were tested before
and after ALA treatment. Results were evaluated using SPSS
15.0 for Windows.
Results. Adiponectin levels were statistically
significantly lower and CRP levels were higher in diabetes
group when compared to control group. Although ALA
treatment caused a slight weight loss, it was not statistically
significant. Appetite scores were decreased in the diabetes
group but it did not cause statistically significant weight loss.
There was no significant change in metabolic parameters or
adiponectin after the treatment.
Conclusions. 600mg/dL ALA treatment for
6 weeks did not favor for metabolic parameters in type 2
diabetes patients. This result might be due to the dose or the
duration of the treatment, genetic predisposition or dietery
habits. Trial of higher doses for long terms might be needed
for recovery.
Keywords: alpha lipoic acid, adiponectin, type 2 diabetes mellitus
Correspondence: Hanife Usta Atmaca MD, Istanbul Training and Research Hospital, Dept. of Internal Medicine, Samatya, Istanbul, 34000, Turkey, E-mail: hanifeusta@yahoo.com